Management of Crohn's disease in adults.

PubWeight™: 1.65‹?› | Rank: Top 3%

🔗 View Article (PMID 9128300)

Published in Am J Gastroenterol on April 01, 1997

Authors

S B Hanauer1, S Meyers

Author Affiliations

1: University of Chicago Pritzker School of Medicine, Illinois, USA.

Articles citing this

Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res (2011) 1.21

New treatments for inflammatory bowel disease. World J Gastroenterol (1998) 1.09

Timing of surgery in Crohn's disease: a key issue in the management. World J Gastroenterol (2008) 0.98

Practical guidelines for the treatment of inflammatory bowel disease. World J Gastroenterol (2007) 0.91

Management of difficult inflammatory bowel disease: where are we now? World J Gastroenterol (2000) 0.90

Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new? World J Gastrointest Endosc (2012) 0.85

Herpes simplex virus colitis in a patient with Crohn's disease and hepatitis B and d cirrhosis. Gastroenterol Hepatol (N Y) (2010) 0.84

Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci (2008) 0.83

Management of Crohn's disease. BMJ (1999) 0.82

Vitamin D-mediated calcium absorption in patients with clinically stable Crohn's disease: a pilot study. Mol Nutr Food Res (2010) 0.81

Anti-TNF antibody treatment of Crohn's disease. Ann Rheum Dis (1999) 0.81

Current use of immunosuppressive agents in inflammatory bowel disease patients in East China. World J Gastroenterol (2009) 0.79

Infliximab treatment for Crohn's disease. Postgrad Med J (2001) 0.77

Re: practice guidelines by Hanauer and Meyers. Am J Gastroenterol (1998) 0.75

Disseminated tuberculosis infection and paradoxical reaction during antimycobacterial treatment related to TNF-alpha blocker agent Infliximab. Respir Med Case Rep (2014) 0.75

Articles by these authors

ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42

Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06

PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91

Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene (1995) 1.83

The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78

The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol Cell Biol (1996) 1.75

Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53

The use of 6-mercaptopurine in adolescents. Gastroenterology (1991) 1.40

Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38

Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27

Q fever in maritime Canada. Can Med Assoc J (1982) 1.25

Sex-linked retinitis pigmentosa: ultrastructure of photoreceptors and pigment epithelium. Invest Ophthalmol Vis Sci (1979) 1.23

Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16

Systemic amyloidosis complicating inflammatory bowel disease. Gastroenterology (1997) 1.10

Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology (1996) 1.09

T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07

Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q. Genomics (1992) 1.05

Guide wire entrapment during PTCA: a potentially dangerous complication. Cathet Cardiovasc Diagn (1987) 1.02

Mitochondrial DNA sequencing of shed hairs and saliva on robbery caps: sensitivity and matching probabilities. J Forensic Sci (1998) 1.01

Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01

Fine-mapping and construction of a bovine contig spanning the ovine callipyge locus. Mamm Genome (2001) 1.01

ETO-2, a new member of the ETO-family of nuclear proteins. Oncogene (1999) 1.01

Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer. J Clin Oncol (1986) 1.00

Detection of tumorigenesis in rat bladders with optical coherence tomography. Med Phys (2001) 1.00

Collagenous gastritis associated with lymphocytic colitis. J Clin Gastroenterol (1996) 1.00

Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99

Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood (1995) 0.98

Enhancing early bladder cancer detection with fluorescence-guided endoscopic optical coherence tomography. Opt Lett (2003) 0.96

Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. J Virol (2001) 0.94

"Natural history" of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology (1984) 0.94

Sterile corneal ulcers after cataract surgery in keratoconjunctivitis sicca. Arch Ophthalmol (1978) 0.94

Chemical changes in the cerebrospinal fluid and brain in magnesium deficiency. Neurology (1968) 0.91

Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. Clin Infect Dis (1995) 0.90

Surgery and its sequelae in Crohn's colitis and ileocolitis. Arch Surg (1981) 0.89

Protamine sulfate-induced cystitis: a model of selective cytodestruction of the urothelium. Urology (2001) 0.88

Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. Gut (1988) 0.88

The child with congenital toxoplasmosis. Curr Clin Top Infect Dis (2000) 0.88

Periileostomy fistulae in Crohn's disease. Ann Surg (1983) 0.87

Cardiovascular responses to upper gastrointestinal endoscopy. Am J Gastroenterol (1978) 0.86

Changes in cerebral blood flow and distribution associated with acute increases in plasma sodium and osmolality of chronic hyponatremic rats. Exp Neurol (2000) 0.86

Mycobacterium avium-intracellulare-associated colitis in a patient with the acquired immunodeficiency syndrome. J Clin Gastroenterol (1984) 0.86

Long-term antigen specific and non-specific T-cell lines and clones in uveitis. Curr Eye Res (1984) 0.84

Acquired cyanotic heart disease secondary to traumatic tricuspid regurgitation. Case report with a review of the literature. Am J Cardiol (1979) 0.84

Knowledge-based simulation of genetic regulation in bacteriophage lambda. Nucleic Acids Res (1984) 0.84

Construction and characterization of an ovine BAC contig spanning the callipyge locus. Anim Genet (2000) 0.83

Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology (1983) 0.83

Excimer laser facilitated percutaneous coronary intervention of a nondilatable coronary stent. Catheter Cardiovasc Interv (2001) 0.83

Sensate radial forearm free flaps in tongue reconstruction. Arch Otolaryngol Head Neck Surg (2001) 0.82

Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8). Oncogene (2000) 0.82

Suppurative bursitis in early childhood. Pediatr Infect Dis (1984) 0.81

Prediction of child abuse in an ambulatory setting. Pediatrics (1982) 0.81

Adult muscle sodium channel alpha-subunit is a gene candidate for malignant hyperthermia susceptibility. Genomics (1992) 0.81

Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81

Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO. Curr Top Microbiol Immunol (1996) 0.81

The place of oral 5-aminosalicylic acid in the therapy of ulcerative colitis. Am J Gastroenterol (1988) 0.81

Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer. Breast Cancer Res Treat (1993) 0.80

Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease? J Clin Gastroenterol (1983) 0.80

Left-handedness and inflammatory bowel disease. J Clin Gastroenterol (1985) 0.80

The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance. J Clin Gastroenterol (1988) 0.79

Ovarian cancer: comparison of observer performance for four methods of interpreting CT scans. Radiology (1999) 0.79

Myocardial uptake of thallium-201 augmented with bicarbonate: concise communication. J Nucl Med (1977) 0.79

Colorectal cancer in regional ileitis. Q J Med (1987) 0.79

Anergy in Crohn's disease. Br Med J (1977) 0.79

Pancreatitis coincident with Crohn's ileocolitis. Report of a case and review of the literature. Dis Colon Rectum (1987) 0.78

The ileum is the major site of absorption of vitamin B12 analogues. Am J Gastroenterol (1989) 0.77

The roentgenographic demonstration of a gastric mucosal laceration (Mallory-Weiss Lesion). Am J Gastroenterol (1977) 0.77

Expression of a unique protein on colon cancer cells that reacts with a novel monoclonal antibody and ulcerative colitis serum. Clin Exp Immunol (1995) 0.77

Clostridium difficile colitis. Am J Gastroenterol (1999) 0.77

Assessing quality of life. Mt Sinai J Med (1983) 0.77

Lenegre's disease in youth. Am Heart J (1977) 0.77

Factors determining programmed stimulation responses and long-term arrhythmic outcome in survivors of ventricular fibrillation with ischemic heart disease. Am Heart J (1988) 0.77

Reduction of gastric ammonia by ampicillin in normal and azotemic subjects. Gastroenterology (1976) 0.76

Gold nanostar substrates for SERS-based chemical sensing in the femtomolar regime. Nanoscale (2014) 0.76

Olsalazine and GI transit in UC. Gut (1988) 0.75

Relations between low rates of in vitro fertilization and induction of sperm acrosome reactions by zona pellucida in the equine species. Anim Reprod Sci (2005) 0.75

Anemia and intestinal dysfunction in former residents of the Caribbean. Arch Intern Med (1977) 0.75

American nursing students in an English maternity setting. J Nurs Educ (1996) 0.75

Olsalazine and sulfasalazine allergy. J Clin Gastroenterol (1988) 0.75

Cryoproteinemia in the cutaneous gangrene of Crohn's disease: a report of two cases. J Clin Gastroenterol (1981) 0.75

Crohn's ileocolitis, cutaneous gangrene and cryoglobulinema. Mt Sinai J Med (1979) 0.75

Corticosteroids in ulcerative colitis. J Clin Gastroenterol (1990) 0.75

Disodium azodisalicylate and sulfasalazine. Am J Gastroenterol (1988) 0.75

Comparison of three mobilization regimens for peripheral blood progenitor cell rescue after high dose chemotherapy. Prog Clin Biol Res (1994) 0.75

Impact of circadian rhythm research on approaches to affective illness. Arch Psychiatr Nurs (1987) 0.75

A gown for all occasions. Mater Manag Health Care (2001) 0.75

Systemic corticosteroid therapy of ulcerative colitis. Gastroenterology (1985) 0.75

The place of steroids in the therapy of toxic megacolon. Gastroenterology (1978) 0.75

Methotrexate and inflammatory bowel disease. Ann Intern Med (1989) 0.75

5-ASA for ulcerative colitis. N Engl J Med (1988) 0.75

Percutaneous transluminal coronary angioplasty: ten years' experience. Prog Cardiovasc Dis (1987) 0.75

ACTH vs. hydrocortisone in ulcerative colitis. Gastroenterology (1983) 0.75

Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera. Clin Chim Acta (1980) 0.75

Free perforation complicating primary adenocarcinoma of the jejunum. Am J Dig Dis (1974) 0.75

Foundations of decision-making: the necessity for philosophical considerations in the physician-patient relationship. J La State Med Soc (1988) 0.75

Echocardiographic practice in a large metropolitan area. Arch Intern Med (1980) 0.75

The role of corticosteroids. Mt Sinai J Med (1983) 0.75

Angiographic coronary morphology in postinfarction angina. Cathet Cardiovasc Diagn (1989) 0.75